Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Biohaven (BHVN) Prices 6.977M Shares Common Offering at $43/Sh
-
Biohaven Announces Pricing Of $300 Million Public Offering Of Common Shares
-
Canaccord Genuity Sees Buying Opportunity in Biohaven Pharmaceutical (BHVN)
-
UPDATE: Canaccord Genuity Defends Biohaven Pharmaceutical Holding (BHVN); 'No News from the Company'
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $89 at Canaccord Genuity; 'Takeover Chatter Not Surprising'
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $46 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $40 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $35 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $34 at Canaccord Genuity
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $39 at Canaccord Genuity